Novavax's experimental vaccine against new virus shows positive results Novavax and The University of Maryland School of Medicine announced that an investigational vaccine candidate developed by Novavax against the recently emerged Middle East Respiratory Syndrome Coronavirus blocked infection in laboratory studies. UM SOM and Novavax also reported that a vaccine candidate against Severe Acute Respiratory Syndrome Coronavirus developed by Novavax on a similar platform also inhibited virus infection. This peer-reviewed manuscript describes a novel method to rapidly develop vaccines against previously unknown viruses, such as MERS-CoV, which appear suddenly and cause severe illnesses in humans.
News For NVAX From The Last 14 Days
Check below for free stories on NVAX the last two weeks.